New drug combo tested for Tough-to-Treat lung cancer
NCT ID NCT07232849
Summary
This study is testing whether a new drug called HRS-4508, when combined with other cancer therapies, can help control advanced lung cancer. It's for people whose cancer has continued to grow despite standard treatments. Researchers will measure how well the combination works and monitor side effects to find the safest, most effective dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200430, China
Contact
-
Zhejiang Tumor Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
Contact
Conditions
Explore the condition pages connected to this study.